Literature DB >> 17483025

Chronic inflammation and bladder cancer.

Dominique S Michaud1.   

Abstract

The relation between Schistosomiasis and bladder cancer is well-established and accounts for the high rates of bladder cancer in a number of developing countries, including Egypt. In developed countries, transitional cell carcinoma is the predominant type of bladder cancer, whereas in Schistosomiasis-endemic regions, squamous cell carcinoma is the most common type. In this review, experimental and observational data on infection, inflammation, and bladder cancer are summarized with special emphasis on transitional cell carcinoma. Findings from numerous studies suggest that inflammation is likely to have an important role in bladder carcinogenesis in developed countries. Future studies need to focus in greater detail on risk factors that increase inflammation of the bladder, examine genetic susceptibility to inflammatory pathways, and include markers of inflammation measured prior to cancer diagnosis. Understanding the role of inflammation on transitional cell carcinogenesis may provide important insights on how to prevent the sixth most common cancer in the United States.

Entities:  

Mesh:

Year:  2007        PMID: 17483025     DOI: 10.1016/j.urolonc.2006.10.002

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  55 in total

Review 1.  Immunological basis in the pathogenesis and treatment of bladder cancer.

Authors:  David B Thompson; Larry E Siref; Michael P Feloney; Ralph J Hauke; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2014-11-13       Impact factor: 4.473

Review 2.  BCG response prediction with cytokine gene variants and bladder cancer: where we are?

Authors:  Dinesh Kumar Ahirwar; Parmeet Kaur Manchanda; Rama Devi Mittal; Hemant K Bid
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-20       Impact factor: 4.553

3.  An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer.

Authors:  Shizhang Ling; Xiaofei Chang; Luciana Schultz; Thomas K Lee; Alcides Chaux; Luigi Marchionni; George J Netto; David Sidransky; David M Berman
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

4.  Complications in adulthood for patients with paediatric genitourinary reconstruction.

Authors:  Oluwarotimi S Nettey; Diana K Bowen; Yahir Santiago-Lastra; Peter Metcalfe; Stephanie J Kielb
Journal:  World J Urol       Date:  2020-06-11       Impact factor: 4.226

5.  Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.

Authors:  Philip Levy Ho; Erica Julianne Lay; Weiguo Jian; Diana Parra; Keith Syson Chan
Journal:  Cancer Res       Date:  2012-04-24       Impact factor: 12.701

6.  Knockdown of PLCε inhibits inflammatory cytokine release via STAT3 phosphorylation in human bladder cancer cells.

Authors:  Xue Yang; Liping Ou; Min Tang; Yin Wang; Xiaorong Wang; E Chen; Jianjun Diao; Xiaohou Wu; Chunli Luo
Journal:  Tumour Biol       Date:  2015-07-09

7.  Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice.

Authors:  Venkateshwar Madka; Altaf Mohammed; Qian Li; Yuting Zhang; Jagan M R Patlolla; Laura Biddick; Stan Lightfoot; Xue-Ru Wu; Vernon Steele; Levy Kopelovich; Chinthalapally V Rao
Journal:  Cancer Prev Res (Phila)       Date:  2014-05-02

8.  CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer.

Authors:  Ming T Cheah; James Y Chen; Debashis Sahoo; Humberto Contreras-Trujillo; Anne K Volkmer; Ferenc A Scheeren; Jens-Peter Volkmer; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

Review 9.  Germline prognostic markers for urinary bladder cancer: obstacles and opportunities.

Authors:  David W Chang; Jian Gu; Xifeng Wu
Journal:  Urol Oncol       Date:  2012 Jul-Aug       Impact factor: 3.498

Review 10.  Role of oestrogen receptors in bladder cancer development.

Authors:  Iawen Hsu; Spencer Vitkus; Jun Da; Shuyuan Yeh
Journal:  Nat Rev Urol       Date:  2013-04-16       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.